97 related articles for article (PubMed ID: 3910387)
1. Long-term experience with lofexidine in the treatment of mild-to-moderate essential hypertension.
Lopez LM; Mehta JL
Drug Intell Clin Pharm; 1985 Dec; 19(12):928-32. PubMed ID: 3910387
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension.
Lopez LM; Mehta JL
Am J Cardiol; 1984 Mar; 53(6):787-90. PubMed ID: 6702628
[TBL] [Abstract][Full Text] [Related]
3. Lofexidine and clonidine in moderate essential hypertension.
Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
[TBL] [Abstract][Full Text] [Related]
4. Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine.
Schultz HS; Chretien SD; Brewer DD; Eltorai MI; Weber MA
J Clin Pharmacol; 1981; 21(2):65-71. PubMed ID: 7229119
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of lofexidine and clonidine given alone or concomitantly with hydrochlorothiazide in hypertensive outpatients.
Beitman RE; Kuzma RJ; McMahon FG; Morledge J; Mroczek W; Rolf CN; Tsai TH
Arzneimittelforschung; 1982; 32(8a):988-93. PubMed ID: 6753858
[No Abstract] [Full Text] [Related]
6. Antihypertensive effects of lofexidine in patients with essential hypertension.
Fagan TC; Bloomfield SS; Cowart TD; Corns-Hurwitz RH; Lipicky RJ; Conradi EC; Hsu CY; Grossman WJ; Harmon GE; Degenhart WJ; Sinkfield AW; Gaffney TE
Br J Clin Pharmacol; 1982 Mar; 13(3):405-10. PubMed ID: 7059442
[TBL] [Abstract][Full Text] [Related]
7. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide.
Aigner A; Schmidt U
Arzneimittelforschung; 1982; 32(8a):976-83. PubMed ID: 6890373
[No Abstract] [Full Text] [Related]
8. Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study.
Kanniainen E; Heikkilä O; Jääskeläinen T; Lilja M; Jounela AJ
Eur J Clin Pharmacol; 1985; 28(1):35-9. PubMed ID: 3886400
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effect of lofexidine with a diuretic in hypertension.
Vlachakis ND; Velasquez M; Alexander N; Maronde RF
Clin Pharmacol Ther; 1983 Dec; 34(6):764-9. PubMed ID: 6357591
[TBL] [Abstract][Full Text] [Related]
10. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
Washton AM; Resnick RB; Geyer G
J Clin Psychiatry; 1983 Sep; 44(9):335-7. PubMed ID: 6355070
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
Dollery CT; Reid JL
Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
[TBL] [Abstract][Full Text] [Related]
12. Comparison of moxonidine and clonidine HCl in treating patients with hypertension.
Plänitz V
J Clin Pharmacol; 1987 Jan; 27(1):46-51. PubMed ID: 3316304
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
[TBL] [Abstract][Full Text] [Related]
14. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of guanfacine: a double-blind cross-over trial compared with clonidine.
Distler A; Kirch W; Lüth B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):49S-53S. PubMed ID: 6994778
[TBL] [Abstract][Full Text] [Related]
16. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
Kahn A; Mumford JP; Rogers GA; Beckford H
Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
[TBL] [Abstract][Full Text] [Related]
17. Alcohol withdrawal syndromes: clinical management with lofexidine.
Cushman P; Forbes R; Lerner W; Stewart M
Alcohol Clin Exp Res; 1985; 9(2):103-8. PubMed ID: 3890587
[TBL] [Abstract][Full Text] [Related]
18. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
20. Animal experiments on the cardiovascular effects of lofexidine.
Graf E; Doppelfeld IS; Prop G
Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
